P0-RafTR mice transgenic mice can be used to conditionally activate the ERK pathway is Schwann cells. They may have applications in studies related to cancer and peripheral neuropathies.
Alison C Lloyd, University College London
Genetic Background | Generation |
---|---|
|
Allele Type |
---|
Transgenic (Inducible, Inserted expressed sequence) |
P0-RafTR mice express the kinase domain of human c-raf-leukemia viral oncogene 1 (Raf Kinase, Raf1)/ER (a tamoxifen inducible human estrogen receptor ligand binding domain) fusion gene under the direction of a modified rat myelin protein zero (Mpz) promoter. Expression of the fusion gene is observed in myelinating Schwann cells. P0 is a glycoprotein located in Schwann cells of the peripheral nervous system. Schwann cells are important for regeneration and restoration of nerve function after injury. Demyelination of Schwann cells has been associated with peripheral neuropathies, neurofibromas, and fibrosarcomas. Tamoxifen administration in carrier mice results in the activation of the RAF kinase-fusion protein in myelinating Schwann cells, followed by severe demyelination within the peripheral nervous system that results in ataxia and impaired motor function. Mice exhibit many of the inflammatory responses important for nerve repair including permeability of the blood nerve barrier and recruitment of macrophages and other inflammatory cells. This phenotype is dose-dependent and reversible upon withdrawal of tamoxifen. Axonal fibers in these mice remain structurally unaffected.
A v-raf-leukemia viral oncogene 1 (Raf Kinase, Raf1)/ER (a tamoxifen inducible human estrogen receptor ligand binding domain) fusion gene was placed under the control of the rat myelin protein zero (Mpz) promoter. This transgenic construct was introduced into C57BL/6J donor oocytes and resulting offspring from founder line A668 were bred to B6CBAF1/J mice. These mice were subsequently bred to B6CBAF1/J mice every generation. Upon arrival at The Jackson Laboratory, mice were bred to B6CBAF1/J mice (Stock No. 100011) to establish the colony.
Expressed Gene | RAF1, Raf-1 proto-oncogene, serine/threonine kinase, human |
---|---|
Expressed Gene | ESR1, estrogen receptor 1, human |
Site of Expression |
Allele Name | transgene insertion A668, Alison Lloyd |
---|---|
Allele Type | Transgenic (Inducible, Inserted expressed sequence) |
Allele Synonym(s) | RafTR; Tg(P0-Raf1/ER)A668Alyd |
Gene Symbol and Name | Tg(Mpz-RAF1/ESR1)A668Ayld, transgene insertion A668, Alison Lloyd |
Gene Synonym(s) | |
Promoter | Mpz, myelin protein zero, rat |
Expressed Gene | RAF1, Raf-1 proto-oncogene, serine/threonine kinase, human |
Expressed Gene | ESR1, estrogen receptor 1, human |
Strain of Origin | C57BL/6J |
Chromosome | UN |
Molecular Note | A v-raf-leukemia viral oncogene 1 (Raf Kinase, Raf1)/ER (a tamoxifen inducible human estrogen receptor ligand binding domain) fusion gene was placed under the control of the rat myelin protein zero (Mpz) promoter. Line 668 was generated. |
When maintaining a live colony, hemizygous mice may be bred to wildtype (non-carrier) mice from the colony or B6CBAF1/J mice (Stock No. 100011).
When using the B6;CBA-Tg(Mpz-RAF1/ESR1)A668Ayld/J mouse strain in a publication, please cite the originating article(s) and include JAX stock #018449 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Hemizygous or non carrier for Tg(Mpz-RAF1/ESR1)A668Ayld |
Frozen Mouse Embryo | B6;CBA-Tg(Mpz-RAF1/ESR1)A668Ayld/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | B6;CBA-Tg(Mpz-RAF1/ESR1)A668Ayld/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | B6;CBA-Tg(Mpz-RAF1/ESR1)A668Ayld/J Frozen Embryo | $3373.50 |
Frozen Mouse Embryo | B6;CBA-Tg(Mpz-RAF1/ESR1)A668Ayld/J Frozen Embryo | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.